MedPath

Phonophoresis Versus Low-Level Laser on Dequervain

Not Applicable
Completed
Conditions
de Quervain Tenosynovitis
Registration Number
NCT06147869
Lead Sponsor
Cairo University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
40
Inclusion Criteria

Inclusion Criteria:<br><br> - <br><br> 1. All participates are clinically diagnosed as they have De Quervain's<br> tenosynovitis . 2. All patient will have positive Finkelstein test. 3. All<br> patient will have severe pain, tenderness and swelling near the base of the<br> thumb over the styloid process of the radius of their dominant hand and<br> limitation of motion of the thumb and wrist joint. 4. Their ages will be ranged<br> from 25-35 years old. 5. Their body mass index (BMI) will not exceed 30 kg/m2<br><br> - The type of delivery is normal and caesarean section.<br><br> - Their parity will be ranged from (2-4 children).<br><br> - All patients will not receive any medical treatment to relieve pain or decrease<br> inflammation.<br><br> - All patients are not pregnant.<br><br>Exclusion Criteria:<br><br> - (1) Patients have diabetic mellitus, hypertension. (2) Patients have any<br> cardiovascular diseases, heart diseases, renal diseases or any diseases (3) Patients<br> have Rheumatoid Arthritis or Gout. (4) Patients have Cervical spondylosis with<br> radiculopathy or any spinal diseases. (5) Patients have leukemia or tumor(benign or<br> malignant)or even breast cancer. (6) Patients have double crush syndrome, carpal<br> bone fracture or joint osteo-arthritis. (7) Patients have any deformities in their<br> hands. (8) Patients have burns, ulcers, open wounds or any skin diseases in their<br> dominant hands. (9) Patients have received medications or have injected with steroid<br> in their tender point.

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Visual analogue scale (VAS)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath